S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%
A daily business newspaper · Founded in 2026

Money Talk

Finance and markets: business, quotes, gold, energy and releases.

Cannara Biotech Taps Nicholas Fozard for CFO Role

Nicholas Fozard, a veteran of the cannabis sector with executive tenures at Organigram and iAnthus, is set to join Cannara Biotech as chief financial officer. He steps into the role previously held by Nicholas Sosiak, who transitioned to the position of chief operating officer earlier this spring.

Cannara Biotech Taps Nicholas Fozard for CFO Role

Fozard brings a specialized background in public-company reporting, manufacturing finance, and capital markets to the Montreal-based firm. His appointment remains subject to the receipt of a mandatory Health Canada security clearance, a standard regulatory step for all officers and directors within the company.

Sosiak, who served as finance chief since 2020, has been managing the handover process since his promotion in April. The leadership shift aims to bolster Cannara’s financial oversight as the company navigates ongoing sector transactions and operational scaling.

Share article
TelegramXFacebook

When reusing this material a link to Money Talk is required.

Comments (0)

Leave a comment

No comments yet. Be the first!